Progress in SCLC: From Deadly to Cure?
Millie Das, MD, of Stanford Cancer Center, discusses the progress in small cell lung cancer treatment.
Source: onclive.com
Millie Das News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Millie Das. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Millie Das Today - Breaking & Trending Today
TKIs, Immunotherapy, and ADCs Amplify the SCLC and NSCLC Treatment Paradigms
Millie Das, MD, highlights early efficacy signals with PARP inhibitors in patients with small cell lung cancer, how overall survival data from the phase 3 ADAURA trial confirm the efficacy of adjuvant osimertinib in patients with non–small cell lung cancer, and which patients may benefit most from immunotherapy as monotherapy or in combination with other agents.
Source: onclive.com
Experts Provide Key Perspectives on the US Cisplatin/Carboplatin Shortage
Experts from various institutions were interviewed by OncLive® at the 24th Annual International Lung Cancer Congress® about the ongoing platinum chemotherapy shortage in the United States.
Source: onclive.com
Dr Das on the Landscape of Current and Emerging ADCs in SCLC
Millie Das, MD, discusses the current landscape of new and emerging ADCs under investigation in small-cell lung cancer and highlights the phase 2 SWOG S1929 study.
Source: onclive.com